Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;94(9):4040-4042.
doi: 10.1002/jmv.27823. Epub 2022 May 16.

Epstein-Barr virus and COVID-19

Arman Shafiee  1 , Sepehr Aghajanian  1 , Mohammad M T Athar  2 , Omid K Gargari  1
Affiliations

Epstein-Barr virus and COVID-19

Arman Shafiee et al. J Med Virol. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The pooled incidence of EBV reactivation. All measures are proportions of EBV reactivated cases among COVID‐19 patients. CI, confidence interval; COVID‐19, coronavirus disease 2019; EBV, Epstein–Barr virus; RE model, random‐effects model.
See this image and copyright information in PMC

References

    1. Dong E, Du H, Gardner L. An interactive web‐based dashboard to track COVID‐19 in real time. Lancet Infect Dis. 2020;20(5):533‐534. - PMC - PubMed
    1. Han Q, Zheng B, Daines L, Sheikh A. Long‐term sequelae of COVID‐19: a systematic review and meta‐analysis of one‐year follow‐up studies on post‐COVID symptoms. Pathogens. 2022;11(2):269. - PMC - PubMed
    1. Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein–Barr virus reactivation. Pathogens. 2021;10(6):763. - PMC - PubMed
    1. Shafiee A, Shamsi S, Kohandel Gargari O, et al. EBV associated T‐and NK‐cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol. 2022. ​:e2328. - PubMed
    1. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB. Immediate early and early lytic cycle proteins are frequent targets of the Epstein–Barr virus‐induced cytotoxic T cell response. J Exp Med. 1997;185(9):1605‐1617. - PMC - PubMed